Katerina Lalatsa

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The blood brain barrier compromises glioblastoma chemotherapy. However high blood concentrations of lipophilic, alkylating drugs result in brain uptake, but cause myelosuppression. We hypothesised that nanoparticles could achieve therapeutic brain concentrations without dose-limiting myelosuppression. Mice were dosed with either intravenous lomustine(More)
  • 1